Bayer Drug Nexavar Approved To Treat Liver Cancer In China
July 28, 2008
Beijing (dbTechno) - The drug company Bayer AG has announced that they have received approval from Chinese regulators for Nexavar to help treat liver cancer.
The new drug, Nexavar, was developed by both Bayer, as well as Onyx Pharmaceuticals. It is in a new class of cancer treatment drugs called kinase inhibitors.
The idea behind the drug is to, instead of going after a tumor, turn off the enzymes which lead to tumor cell growth or division.
The approval came after two international Phase III trials were carried out, with over 800 patients taking part.
Nexavar has now become the first drug to treat liver cancer in China that will not be directly applies to tumors.
China is hit hard by liver cancer, as more than 340,000 new cases are diagnosed each year.
Nexavar is approved in over 40 countries to treat liver cancer, and more than 70 countries to treat kidney cancer.
Breaking News
Lady Gaga sued by former boyfriend Rob FusariLady Gaga is being sued by a former boyfriend who alleges that she owes him money for helping get her music career off the...
Drug-resistant tuberculosis up across India and ChinaThe World Health Organization (WHO) says it does not have enough information at hand to say either way if cases of drug-resistant...
Elin has not been seen at Tiger’s home for daysWhere in the world is Elin is the question of the week as the wife of Tiger Woods has gone missing. She has not been seen...
Comments
All comments are moderated.
If your comment is approved, it will be posted within 24 hours